ISMOX
Price
$4.19
Change
+$0.08 (+1.95%)
Updated
Dec 20 closing price
PMAQX
Price
$45.12
Change
+$0.54 (+1.21%)
Updated
Dec 20 closing price
Ad is loading...

ISMOX vs PMAQX

Header iconISMOX vs PMAQX Comparison
Open Charts ISMOX vs PMAQXBanner chart's image
Voya MidCap Opportunities Port S
Price$4.19
Change+$0.08 (+1.95%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$45.12
Change+$0.54 (+1.21%)
VolumeN/A
CapitalizationN/A
ISMOX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ISMOX vs. PMAQX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISMOX is a StrongBuy and PMAQX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 28.8B vs. ISMOX (1.15B). PMAQX pays higher dividends than ISMOX: PMAQX (0.10) vs ISMOX (0.00). ISMOX was incepted earlier than PMAQX: ISMOX (24 years) vs PMAQX (8 years). ISMOX is a more actively managed with annual turnover of: 74.00 vs. PMAQX (10.10). ISMOX (0) and PMAQX (0) have matching initial minimum investment requirements. ISMOX (19.03) and PMAQX (18.68) have marching annual gain over last year. PMAQX return over 5 years is better than : 46.56 vs. ISMOX (-67.62).
ISMOXPMAQXISMOX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years8 years-
Gain YTD18.36217.684104%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B28.8B4%
Annual Yield % from dividends0.000.10-
Returns for 1 year19.0318.68102%
Returns for 3 years-74.0411.40-650%
Returns for 5 years-67.6246.56-145%
Returns for 10 years-71.55N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGIC12.040.14
+1.18%
Magic Software Enterprises Ltd
DAY74.840.84
+1.14%
Dayforce
VSH17.180.17
+1.00%
Vishay Intertechnology
QUIK7.84-0.12
-1.51%
QuickLogic Corp
ATXI1.77-0.03
-1.67%
Avenue Therapeutics